Joseph Elijah

1 INTRODUCTION Cystic fibrosis (CF) is a chronic and progressive disease which results in significant lung damage as a result of the defect in CF transmembrane regulator (CFTR) protein trafficking and conductance within the respiratory tract.1, 2 Use of CFTR modulators aids in restoring CFTR channel function, resulting in pulmonary and extrapulmonary benefits in people with CF (pwCF) with mild to moderate lung dysfunction.3-6 The sequelae which contribute to development of progressive lung...

ASCO 2023, one of the most influential oncology clinical academic meetings in the world, will be held on June 2-6 (Eastern time) in Chicago, United States.